prostiva patient seminar presentation 10.31.11 - urologix filebph: 5-year results of a prospective,...

28
MC1653 Rev A 11/11

Upload: nguyenphuc

Post on 26-May-2019

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

MC1653 Rev A 11/11

Page 2: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Prostiva® RF Therapy:Prostiva® RF Therapy: Lasting Relief without Chronic Medication

MC1653 Rev A 11/11 2

Page 3: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Wh t i E l d P t t ?What is Enlarged Prostate?

B i t ti h l i (BPH) i l k l d t t• Benign prostatic hyperplasia (BPH) is commonly known as enlarged prostate

• Enlarged prostate is a non-cancerous condition in which prostate cells increase in number

• This growth causes the gland to compress the urethra, making urination painful or difficult

• Enlarged prostate affects more than half of all men over the age of 50¹

1 Contemporary Diagnosis and Management of The Enlarged Prostate, McVary, K., Helfand, B., Miner, M., Handbooks in Health Care Co., pg 24, ©2011,

MC1653 Rev A 11/11 3

Page 4: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

M l A tMale Anatomy

MC1653 Rev A 11/11 4

Page 5: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Normal vs Enlarged ProstateNormal vs. Enlarged Prostate

Bladder Bladder

NormalProstate

EnlargedProstate

Urethra Urethra

Prostate Prostate

MC1653 Rev A 11/11 5

Page 6: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Symptoms of Enlarged ProstateSymptoms of Enlarged Prostate

F t d t d t i t• Frequent and urgent need to urinate

• Difficulty starting urination

• Weak urine flow

• Stopping and starting of urine flow

• Feeling of being unable to completely empty the bladder

• Urinary incontinence

• Interference with sexual activity

MC1653 Rev A 11/11 6

Page 7: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

E l ti E l d P t tEvaluating Enlarged Prostate

S t• Symptom score

• Digital rectal exam

• Urine flow rate

• PSA

MC1653 Rev A 11/11 7

Page 8: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Treatment Decision Model

Watchful Waiting

MedicationMedication

Prostiva® RF Therapy

Surgery

MC1653 Rev A 11/11 8

Page 9: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

T t t O tiTreatment Options

Drug Therapy• Alpha-blockers

• 5 ARI‘s (Alpha Reductase Inhibitors)

• Combination Therapy

MC1653 Rev A 11/11 9

Page 10: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

O h T O iOther Treatment Options

SurgerySurgery • Transurethral resection of the prostate (TURP)

• Laser

Office-Based Treatments• Prostiva®

• Cooled ThermoTherapy™

• Prolieve®

• Thermatrx®

MC1653 Rev A 11/11 10

Page 11: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

BPH M d A N t F EBPH Meds Are Not For Everyone

48% f h li i ll• 48% of men have no clinically significant symptom improvement1

• 23% of men taking using medical combination therapy for BPH maycombination therapy for BPH may experience impotence2

• The cost of BPH medications may be an expensive and inconvenient pburden

1Wei, et al, High Rates for Continued BPH Medical Therapy Among Non-Responders, Abstract 498, AUA Annual Meeting 2010.

2Proscar Labeling 9631304, www.fda.gov.

MC1653 Rev A 11/11 11

Page 12: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

MC1653 Rev A 11/11 12

Page 13: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

P ti ® RF ThProstiva® RF Therapy

• Single, non-operative procedureg p p

• Proven lasting results1

• Cost effective

1 Hill, B., et. al., Transurethral Needle Ablation vs TURP for the Treatment of Symptomatic BPH: 5-Year Results of a Prospective, Randomized, Multicenter Clinical Trial, Journal of Urology Vol 171, 2336-2340, June 2004

MC1653 Rev A 11/11 13

Page 14: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Prostiva® RF Therapy

• Delivers radio frequency (RF) energy directly into the prostate

• Energy is precisely targeted to• Energy is precisely targeted to specific prostatic tissue

• Improves flow of urine and relief of urinary symptomsurinary symptoms

(click on box to start animation)

MC1653 Rev A 11/11 14

Page 15: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

AfAfter treatment

• Most patients resume normal activities in a few days

• Many patients notice symptoms improving within 2-8 weeks

MC1653 Rev A 11/11 15

Page 16: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Imagine a Happier YouImagine a Happier You

• More active

• More satisfied

• More alive

MC1653 Rev A 11/11 16

Page 17: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

®The Prostiva® RF Therapy Advantage

S f ti t t t• Safe, proven, non-operative treatment

• Lasting relief without chronic medication1

• Performed in the doctor’s office

• No surgery or general anesthesia

1 Hill, B., et. al., Transurethral Needle Ablation vs TURP for the Treatment of Symptomatic BPH: 5-Year Results of a Prospective, Randomized, Multicenter Clinical Trial, Journal of Urology Vol 171, 2336-2340, June 2004

MC1653 Rev A 11/11 17

Page 18: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

MC1653 Rev A 11/11 18

Page 19: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

MC1653 Rev A 11/11 19

Page 20: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Common QuestionsCommon Questions

MC1653 Rev A 11/11 20

Page 21: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Common QuestionsCommon Questions

Is the procedure painful?Is the procedure painful?

MC1653 Rev A 11/11 21

Page 22: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Common QuestionsCommon Questions

Are the results long-lasting?Are the results long-lasting?

MC1653 Rev A 11/11 22

Page 23: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Common QuestionsCommon Questions

Is Prostiva® RF Therapy expensive?

MC1653 Rev A 11/11 23

Page 24: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Common QuestionsCommon Questions

Is it covered by insurance?Is it covered by insurance?

MC1653 Rev A 11/11 24

Page 25: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Any questions ’d lik k?you’d like to ask?

MC1653 Rev A 11/11 25

Page 26: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

www.urologix.comg

MC1653 Rev A 11/11 26

Page 27: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Make an appointment today!

MC1653 Rev A 11/11 27

Page 28: Prostiva Patient Seminar Presentation 10.31.11 - Urologix fileBPH: 5-Year Results of a Prospective, Randomized , Multicenter Clinical Trial, Journal of Urology ... • Most patients

Prostiva RF TherapyProstiva RF Therapy

Indications: Prostiva RF Therapy is indicated for the treatment of symptoms due t i tfl b t ti d t b i t ti h l i (BPH)to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men over the age of 50 with prostate sizes between 20cc and 50cc.

Adverse Events: Side effects may include obstruction, bleeding, pain/discomfort, urgency, frequency and urinary tract infection.

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. For a listing of indications, contraindications, precautions and warnings, please refer to the System User Guide.

MC1653 Rev A 11/11